<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03479099</url>
  </required_header>
  <id_info>
    <org_study_id>2018-01-081</org_study_id>
    <nct_id>NCT03479099</nct_id>
  </id_info>
  <brief_title>Liquid Biopsy in Lung Cancer</brief_title>
  <official_title>Clinical Utility of Combined CTC and ctDNA Assay in the Diagnosis of Primary Lung Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess clinical utility of combined circulating tumor cell
      (CTC) and circulating tumor DNA (ctDNA) in the diagnosis of primary lung cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The peripheral blood and tumor tissue samples are collected from the participants.CTC and
      ctDNA are analyzed from the blood samples.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 12, 2018</start_date>
  <completion_date type="Anticipated">March 11, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 11, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic sensitivity of combined CTC and ctDNA</measure>
    <time_frame>1 year</time_frame>
    <description>To compared the sensitivity of combined CTC and ctDNA with those of CTC and ctDNA alone in diagnosis of primary lung cancer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnostic accuracy of combined CTC and ctDNA</measure>
    <time_frame>1 year</time_frame>
    <description>To compared the accuracy of combined CTC and ctDNA with those of CTC and ctDNA alone in diagnosis of primary lung cancer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diagnostic specificity of CTC and ctDNA</measure>
    <time_frame>1 year</time_frame>
    <description>To compared the specificity of combined CTC and ctDNA with those of CTC and ctDNA alone in diagnosis of primary lung cancer</description>
  </secondary_outcome>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Lung Cancer (Diagnosis)</condition>
  <condition>Circulating Tumor Cell</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The subjects who are referred for the evaluation and management of primary lung cancer in
        the tertiary care center
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with histology-proven lung cancer or a clinical suspicion of lung cancer

          -  Age &gt;=18, &lt; 80 years

          -  No previous history of cancer treatment within 5 years

          -  Patients who agree to participate

        Exclusion Criteria:

          -  Patients who have been diagnosed with malignancy within 5 years

          -  Patients with previous history of lung cancer

          -  Patients who have uncontrolled coagulopathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sang-Won Um, MD, PhD</last_name>
    <phone>+82-2-3410-1645</phone>
    <email>sangwonum@skku.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sunyoung Kim</last_name>
    <phone>+82-2-3410-3429</phone>
    <email>sunyoung75.kim@samsung.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>06278</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sang-Won Um, MD</last_name>
      <phone>+82-2-3410-1645</phone>
      <email>sangwonum@skku.edu</email>
    </contact>
    <contact_backup>
      <last_name>Sunyoung Kim</last_name>
      <phone>+82-2-3410-3429</phone>
      <email>sunyoung72.kim@samsung.com</email>
    </contact_backup>
    <investigator>
      <last_name>Sang-Won Um, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2018</study_first_submitted>
  <study_first_submitted_qc>March 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2018</study_first_posted>
  <last_update_submitted>March 18, 2018</last_update_submitted>
  <last_update_submitted_qc>March 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>Sang-Won Um</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Lung cancer</keyword>
  <keyword>Circulating Tumor Cell</keyword>
  <keyword>Cell-Free Tumor DNA</keyword>
  <keyword>Liquid Biopsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Neoplastic Cells, Circulating</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

